ATE122394T1 - Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung. - Google Patents

Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.

Info

Publication number: ATE122394T1
Authority: AT; Austria
Prior art keywords: iddm; cell antigens; ica; molecular cloning; cells
Prior art date: 1989-02-17

Application number

AT90102179T

Other languages

English (en)

Inventor

Daniel Rabin

Original Assignee

Miles Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-17

Filing date

1990-02-03

Publication date

1995-05-15

1990-02-03 Application filed by Miles Inc filed Critical Miles Inc

1995-05-15 Application granted granted Critical

1995-05-15 Publication of ATE122394T1 publication Critical patent/ATE122394T1/de

Links

239000000427 antigen Substances 0.000 title abstract 2
102000036639 antigens Human genes 0.000 title abstract 2
108091007433 antigens Proteins 0.000 title abstract 2
238000010369 molecular cloning Methods 0.000 title 1
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
210000004153 islets of langerhan Anatomy 0.000 abstract 2
108060003951 Immunoglobulin Proteins 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
102000007079 Peptide Fragments Human genes 0.000 abstract 1
108010033276 Peptide Fragments Proteins 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
210000003719 b-lymphocyte Anatomy 0.000 abstract 1
230000000903 blocking effect Effects 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
238000010367 cloning Methods 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
102000018358 immunoglobulin Human genes 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT90102179T 1989-02-17 1990-02-03 Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung. ATE122394T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31254389A	1989-02-17	1989-02-17
US44170389A	1989-12-04	1989-12-04

Publications (1)

Publication Number	Publication Date
ATE122394T1 true ATE122394T1 (de)	1995-05-15

Family

ID=26978437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90102179T ATE122394T1 (de)	1989-02-17	1990-02-03	Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.

Country Status (14)

Country	Link
EP (1)	EP0383129B1 (de)
JP (1)	JP2858467B2 (de)
AT (1)	ATE122394T1 (de)
AU (1)	AU626636B2 (de)
CA (1)	CA2010275C (de)
DE (1)	DE69019190T2 (de)
DK (1)	DK0383129T3 (de)
ES (1)	ES2072928T3 (de)
FI (1)	FI103730B1 (de)
GR (1)	GR3017019T3 (de)
IE (1)	IE66997B1 (de)
IL (1)	IL93397A (de)
NO (1)	NO306996B1 (de)
PT (1)	PT93166B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5645998A (en)	1988-12-13	1997-07-08	University Of Florida Research Foundation	Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) *	1988-12-13	1999-12-14	University Of Florida	Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) *	1989-01-30	1990-08-08	Shionogi & Co Ltd	新規ｒｅｇ蛋白質
US5175085A (en) *	1990-02-20	1992-12-29	Board Of Regents, The University Of Texas System	Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
US5744327A (en) *	1990-02-20	1998-04-28	Board Of Regents, The University Of Texas System	Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) *	1991-06-03	1995-06-27	Board Of Regents, The University Of Texas System	Engineered cells producing insulin in response to glucose
WO1992004632A1 (en)	1990-09-07	1992-03-19	The Regents Of The University Of California	Methods for the diagnosis and treatment of diabetes
US5674978A (en) *	1990-09-21	1997-10-07	The Regents Of The University Of California	Peptides derived from glutamic acid decarboxylase
US5998366A (en) *	1990-09-21	1999-12-07	The Regents Of The University Of California	Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en)	1990-09-21	2004-01-27	The Regents Of The University Of California	Cloned glutamic acid decarboxylase
WO1992006105A1 (en) *	1990-10-02	1992-04-16	Trigen Incorporated	Antibodies and methods for diagnosis and treatment of diabetes
JPH06508030A (ja) *	1991-05-15	1994-09-14	ザイモジェネティクス，インコーポレイティド	ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現
US5792656A (en) *	1991-06-03	1998-08-11	Board Of Regents, The University Of Texas System	Methods of preparing genetically engineered cells that produce insulin in response to glucose
WO1993016725A1 (en) *	1992-02-27	1993-09-02	The Board Of Trustees Of The Leland Stanford Junior University	Early antigen for autoimmune diabetes
US5200318A (en) *	1992-05-13	1993-04-06	Miles Inc.	Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) *	1995-05-30	1996-12-05	Fujisawa Pharmaceutical Co., Ltd.	Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en)	1996-03-06	1997-09-22	University Of Washington	Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
AU7159898A (en) *	1997-04-25	1998-11-24	Genetics Institute Inc.	Secreted proteins and polynucleotides encoding them
CN110244051A (zh) *	2019-07-05	2019-09-17	许昌学院	一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE53862T1 (de) *	1982-01-22	1990-06-15	Cetus Corp	Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) *	1983-09-11	1988-03-31	Yeda Res & Dev	Compositions containing cell membrane proteins and process for their preparation
WO1986007464A1 (en) *	1985-06-14	1986-12-18	Genetic Systems Corporation	Methods for identifying alleles associated with increased risk of diabetes
CA1327162C (en) *	1987-04-09	1994-02-22	Board Of Trustees Of The Leland Stanford Junior University (The)	Method for prophylactically treating an individual for an autoimmune disease
EP0359783B2 (de) *	1987-06-24	2002-04-17	Autoimmune, Inc.	Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen

1990
- 1990-02-01 NO NO900474A patent/NO306996B1/no not_active IP Right Cessation
- 1990-02-03 DE DE69019190T patent/DE69019190T2/de not_active Expired - Lifetime
- 1990-02-03 AT AT90102179T patent/ATE122394T1/de not_active IP Right Cessation
- 1990-02-03 EP EP90102179A patent/EP0383129B1/de not_active Expired - Lifetime
- 1990-02-03 ES ES90102179T patent/ES2072928T3/es not_active Expired - Lifetime
- 1990-02-03 DK DK90102179.0T patent/DK0383129T3/da active
- 1990-02-14 IL IL93397A patent/IL93397A/xx not_active IP Right Cessation
- 1990-02-15 PT PT93166A patent/PT93166B/pt not_active IP Right Cessation
- 1990-02-15 FI FI900759A patent/FI103730B1/fi active IP Right Grant
- 1990-02-16 JP JP2034016A patent/JP2858467B2/ja not_active Expired - Lifetime
- 1990-02-16 IE IE58990A patent/IE66997B1/en not_active IP Right Cessation
- 1990-02-16 AU AU49883/90A patent/AU626636B2/en not_active Expired
- 1990-02-16 CA CA002010275A patent/CA2010275C/en not_active Expired - Lifetime
1995
- 1995-08-02 GR GR950402141T patent/GR3017019T3/el unknown

Also Published As

Publication number	Publication date
FI103730B (fi)	1999-08-31
AU4988390A (en)	1990-08-23
NO900474L (no)	1990-08-20
EP0383129A2 (de)	1990-08-22
EP0383129A3 (de)	1991-07-31
NO900474D0 (no)	1990-02-01
IE66997B1 (en)	1996-02-21
DE69019190T2 (de)	1995-09-14
JPH0347133A (ja)	1991-02-28
ES2072928T3 (es)	1995-08-01
PT93166A (pt)	1990-08-31
DE69019190D1 (de)	1995-06-14
DK0383129T3 (da)	1995-10-09
PT93166B (pt)	1997-11-28
JP2858467B2 (ja)	1999-02-17
FI900759A0 (fi)	1990-02-15
CA2010275C (en)	2000-08-29
IL93397A0 (en)	1990-11-29
GR3017019T3 (en)	1995-11-30
IL93397A (en)	1997-06-10
CA2010275A1 (en)	1990-08-17
IE900589L (en)	1990-08-17
FI103730B1 (fi)	1999-08-31
NO306996B1 (no)	2000-01-24
EP0383129B1 (de)	1995-05-10
AU626636B2 (en)	1992-08-06

Legal Events

Date	Code	Title
1995-08-15	EEFA	Change of the company name
1995-12-15	UEP	Publication of translation of european patent specification
2010-05-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE122394T1 (de)	1995-05-15	Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.
BR9809443A (pt)	2000-06-13	Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
Caruso et al.	1990	Natural antibodies to IFN-gamma in man and their increase during viral infection.
PT835266E (pt)	2005-07-29	Superantigenios modificados / quimericos e seu uso
ATE87655T1 (de)	1993-04-15	Markierer der t-zelle aktivierung.
DE3650753D1 (de)	2001-05-03	Auf einmaligen sequenzen innerhalb des veränderlichen gebiets des t-zellrezeptors basierte diagnosemittel und deren verwendung
ATE132197T1 (de)	1996-01-15	Monoklonale antikörper
DE59010925D1 (de)	2001-11-08	Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
RU94046414A (ru)	1996-11-10	Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
WO1996021734A3 (en)	1996-11-28	P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DE3887750D1 (de)	1994-03-24	Selektive entfernung von immunkomplexen.
ES2133269T3 (es)	1999-09-16	Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
ATE87487T1 (de)	1993-04-15	Rekombinante hiv-2 polypeptide.
ATE94880T1 (de)	1993-10-15	Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
EP0293827A3 (de)	1991-03-20	Probe für Leishmaniosis
DE3877136D1 (de)	1993-02-11	Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
FI870501L (fi)	1987-08-08	Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
KR920002631A (ko)	1992-02-28	면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
KR950000879A (ko)	1995-01-03	신규한 인간 면역결핍 바이러스-2(hiv-2)